Marisa M Magaña

Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival

David S. K. Lu, S. Makani, D. Boffa, 2017, Cancer Epidemiology, Biomarkers & Prevention.

High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension

D. Ngo, V. Woods, T. Morris, 2009 .

Thoracic Extramedullary Hematopoiesis Mimicking Metastatic Cancer.

S. Makani, C. Jamieson, Huan-You Wang, 2016, Journal of bronchology & interventional pulmonology.

Abnormally sialylated fibrinogen gamma-chains in a patient with chronic thromboembolic pulmonary hypertension.

Virgil L. Woods, R. Gruppo, T. Morris, 2007, Thrombosis research.

Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review

R. Garfein, A. Catanzaro, T. Rodwell, 2012, PloS one.

Diagnostic approach to deep venous thrombosis and pulmonary embolism in the critical care setting.

P. Fedullo, Robert S. Bercovitch, Marisa M Magaña, 2011, Critical care clinics.

High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Virgil L. Woods, D. Ngo, T. Morris, 2009, Blood.

High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Virgil L. Woods, D. Ngo, T. Morris, 2009, Blood.